Application 021460

Type
NDA
Sponsor
BRISTOL MYERS SQUIBB

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001METAGLIPGLIPIZIDE; METFORMIN HYDROCHLORIDETABLET;ORAL2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002METAGLIPGLIPIZIDE; METFORMIN HYDROCHLORIDETABLET;ORAL2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003METAGLIPGLIPIZIDE; METFORMIN HYDROCHLORIDETABLET;ORAL5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
36995SUPPL2013-10-22
5448SUPPL2013-10-16
15526SUPPL2011-02-04
27853SUPPL2011-02-03
27852SUPPL2009-11-25
36994SUPPL2009-09-18
36993SUPPL2008-08-26
27851SUPPL2008-08-20
27850SUPPL2007-07-05
36992SUPPL2007-06-27
42178ORIG2003-04-30
36991ORIG2002-10-21
5447ORIG2002-10-21